InvestorsHub Logo
Followers 15
Posts 1049
Boards Moderated 0
Alias Born 04/07/2014

Re: livendi post# 136003

Wednesday, 01/26/2022 3:34:23 PM

Wednesday, January 26, 2022 3:34:23 PM

Post# of 140474
Liv,

Why are you still trying to make reality into something it’s not. The status of Enos and company doesn’t have anything to do with posters.

If you perceive them as negative, that’s fine. But it is based solely 100% on the performance of the company.

Let’s recap, first it was going to be December because the bigwigs were coming into Chapel Hill. Then it was gonna be end of year. Then it was going to be when they announced the 4th mile stone. No wait, it will be another 30 days when they announce receipt of final payment.

Now the tag line is “the runway is clear for another big company to step in?”

C’mon, there is no interest. What is the percentage people were stating that MDT acquired a company that they got into a partnership with… over 95%? MDT got the core IP for $10 million and walked… even with an opportunity to snatch this up at next to nothing they passed. And don’t think their new manufacturing partner doesn’t know their payment history. As cash gets low they won’t be working on credit.

I posted long ago this was going to be worse than Hansen Medical for investors. How do they raise $$ now? They have burned every investment class multiple times. No one will vote for a RS and they can’t raise tens of millions of $ at .30 which is 20% discount off .50 (standard offering price) where this will be by the end of week.

Let’s be honest. There is no path where longs do much more than breakeven at best after 10 yrs and that is with a company jumping in and buying them at $2 to $3 in next six month and that is a huge stretch because we know whatever they were telling us about the status of the robot is worse. Two years ago it was supposedly just a software issue. The fact that they haven’t been able to announce a complete hardware and software design freeze in that amount of time is unfathomable.

This has nothing to do with the FDA. A De Novo pathway pathway would not add anywhere near the amount of time that they are saying and sourcing is just a BS smoke screen. Their problem is they have a robot issue they don’t know how to fix.

BelizeMe